A detailed history of Nebula Research & Development LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 2,332 shares of MEDP stock, worth $766,201. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,332
Previous 4,478 47.92%
Holding current value
$766,201
Previous $1.49 Billion 48.17%
% of portfolio
0.09%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$308.93 - $363.58 $662,963 - $780,242
-2,146 Reduced 47.92%
2,332 $775 Million
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $1.44 Million - $2.05 Million
4,478 New
4,478 $1.49 Billion

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.